Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Mycobacterium Marinum Treatment & Management

  • Author: Shirin A Mazumder, MD; Chief Editor: Mark R Wallace, MD, FACP, FIDSA  more...
 
Updated: Oct 07, 2015
 

Medical Care

The mainstay of treatment in M marinum infection is antimicrobial therapy. The duration of therapy is not well defined, but treatment of skin and soft-tissue infections should be continued for 1-2 months after resolution of symptoms and lesions. Therefore, the treatment duration is typically 3-4 months, longer if deeper structures are involved. Some authors have suggested a minimum duration of 6 months. In some cases, a treatment duration of up to 2 years has been reported. Combination treatment with 2 active agents is preferred, although success has been obtained with single-agent approach. Spontaneous resolution of M marinum infection has been reported.

Next

Surgical Care

Surgical drainage of skin lesions may be unnecessary. A French study revealed no clear benefit or change in outcome using a concomitant surgical approach. Deeper-structure infections may require surgery, although its definite role is not well established. Reports have suggested that antibiotic therapy alone is enough to cure most patients and that additional surgical debridement provides cure in remaining cases.

Previous
Next

Consultations

An infectious disease specialist can establish the diagnosis and suggest management. A dermatologist can also provide expertise.

Previous
 
 
Contributor Information and Disclosures
Author

Shirin A Mazumder, MD Assistant Professor, Assistant Infectious Disease Fellowship Program Director, Division of Infectious Diseases, Department of Internal Medicine, University of Tennessee Health Science Center

Shirin A Mazumder, MD is a member of the following medical societies: American Medical Association, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, Infectious Diseases Society of St Louis

Disclosure: Nothing to disclose.

Coauthor(s)

Michael Gelfand, MD, FACP Chief, Professor, Department of Internal Medicine, Division of Infectious Diseases, Methodist Healthcare of Memphis, University of Tennessee Health Science Center College of Medicine

Michael Gelfand, MD, FACP is a member of the following medical societies: American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, Southern Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Aaron Glatt, MD Chief Administrative Officer, Executive Vice President, Mercy Medical Center, Catholic Health Services of Long Island

Aaron Glatt, MD is a member of the following medical societies: American College of Chest Physicians, American Association for Physician Leadership, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Infectious Diseases Society of America, International AIDS Society, Society for Healthcare Epidemiology of America

Disclosure: Nothing to disclose.

Chief Editor

Mark R Wallace, MD, FACP, FIDSA Clinical Professor of Medicine, Florida State University College of Medicine; Clinical Professor of Medicine, University of Central Florida College of Medicine

Mark R Wallace, MD, FACP, FIDSA is a member of the following medical societies: American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, International AIDS Society, Florida Infectious Diseases Society

Disclosure: Nothing to disclose.

Additional Contributors

Klaus-Dieter Lessnau, MD, FCCP Clinical Associate Professor of Medicine, New York University School of Medicine; Medical Director, Pulmonary Physiology Laboratory; Director of Research in Pulmonary Medicine, Department of Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital

Klaus-Dieter Lessnau, MD, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, American Thoracic Society, Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Acknowledgements

Raphael J Kiel, MD Associate Professor of Medicine, Wayne State University School of Medicine; Associate Professor of Medicine, Oakland University William Beaumont School of Medicine; Consulting Staff, Infectious Diseases Division, William Beaumont Hospital; Consulting Staff, Infectious Diseases Division Providence Hospital

Raphael J Kiel, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine and American Geriatrics Society

Disclosure: Nothing to disclose.

Alexandre Lacasse, MD, MSc Internal Medicine Faculty, Assistant Director, Medicine Clinic, Infectious Disease Consultant, St Mary's Health Center

Alexandre Lacasse, MD, MSc is a member of the following medical societies: American College of Physicians, American Medical Association, Association of Program Directors in Internal Medicine, Infectious Diseases Society of America, and Society for Healthcare Epidemiology of America

Disclosure: Nothing to disclose.

References
  1. Slany M, Jezek P, Fiserova V, Bodnarova M, Stork J, Havelkova M, et al. Mycobacterium marinum infections in humans and tracing of its possible environmental sources. Can J Microbiol. 2011 Dec 19. [Medline].

  2. Feng Y, Xu H, Wang H, Zhang C, Zong W, Wu Q. Outbreak of a cutaneous Mycobacterium marinum infection in Jiangsu Haian, China. Diagn Microbiol Infect Dis. 2011 Nov. 71(3):267-72. [Medline].

  3. Dodiuk-Gad R, Dyachenko P, Ziv M, Shani-Adir A, Oren Y, Mendelovici S, et al. Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases. J Am Acad Dermatol. 2007 Sep. 57(3):413-20. [Medline].

  4. Barr KL, Lowe L, Su LD. Mycobacterium marinum infection simulating interstitial granuloma annulare: a report of two cases. Am J Dermatopathol. 2003 Apr. 25(2):148-51. [Medline].

  5. Dolenc-Voljc M, Zolnir-Dovc M. Delayed diagnosis of Mycobacterium marinum infection: A case report and review of the literature. Acta Dermatovenerol Alp Pannonica Adriat. 2010. 19(2):35-9. [Medline].

  6. Van Herendael BH, Dreessen P, Jeurissen A. Fishy Business: the Value of the QuantiFERON-TB Test in the Diagnosis of Mycobacterium marinum Skin Lesions. Clinical Microbiology Newsletter. June 2012. 34 (12):98–100.

  7. Safdar N, Abad CL, Kaul DR, Saint S. Clinical problem-solving. Skin deep. N Engl J Med. 2012 Apr 5. 366(14):1336-40. [Medline].

  8. Streit M, Böhlen LM, Hunziker T, Zimmerli S, Tscharner GG, Nievergelt H, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol. 2006 Jan-Feb. 16(1):79-83. [Medline].

  9. Tsai HC, Lee SS, Wann SR, Chen YS, Liu YW, Liu YC. Mycobacterium marinum tenosynovitis: three case reports and review of the literature. Jpn J Infect Dis. 2006 Oct. 59(5):337-40. [Medline].

  10. Parrish N, Luethke R, Dionne K, Carroll K, Riedel S. Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics. J Clin Microbiol. 2011 May. 49(5):2056-8. [Medline]. [Full Text].

  11. Awais A, Tam CS, Kontoyiannis D, et al. Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia. Clin Infect Dis. 2008 Apr 1. 46(7):e69-71. [Medline].

  12. Jernigan JA, Farr BM. Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature. Clin Infect Dis. 2000 Aug. 31(2):439-43. [Medline].

  13. Kishihara Y, Nakashima K, Nukina H, et al. [Two cases of acquired immunodeficiency syndrome with disseminated non-tuberculous mycobacterial infection]. Kansenshogaku Zasshi. 1993 Dec. 67(12):1223-7. [Medline].

  14. Rallis E, Koumantaki-Mathioudaki E, Frangoulis E, Chatziolou E, Katsambas A. Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol. 2007. 8(6):385-8. [Medline].

  15. Bouricha M, Castan B, Duchene-Parisi E, Drancourt M. Mycobacterium marinum infection following contact with reptiles: vivarium granuloma. Int J Infect Dis. 2014 Apr. 21:17-8. [Medline].

  16. Phan TA, Relic J. Sporotrichoid Mycobacterium marinum infection of the face following a cat scratch. Australas J Dermatol. 2010 Feb. 51(1):45-8. [Medline].

  17. Adhikesavan LG, Harrington TM. Local and disseminated infections caused by Mycobacterium marinum: an unusual cause of subcutaneous nodules. J Clin Rheumatol. 2008 Jun. 14(3):156-60. [Medline].

  18. Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med. 2002 Aug 12-26. 162(15):1746-52. [Medline].

  19. Barton A, Bernstein RM, Struthers JK, et al. Mycobacterium marinum infection causing septic arthritis and osteomyelitis. Br J Rheumatol. 1997 Nov. 36(11):1207-9. [Medline].

  20. Bartralot R, Garcia-Patos V, Sitjas D, et al. Clinical patterns of cutaneous nontuberculous mycobacterial infections. Br J Dermatol. 2005 Apr. 152(4):727-34. [Medline].

  21. Bråbäck M, Riesbeck K, Forsgren A. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother. 2002 Apr. 46(4):1114-6. [Medline].

  22. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med. 1994 Jun 27. 154(12):1359-64. [Medline].

  23. El-Etr SH, Subbian S, Cirillo SL, et al. Identification of two Mycobacterium marinum loci that affect interactions with macrophages. Infect Immun. 2004 Dec. 72(12):6902-13. [Medline].

  24. Ena P, Sechi LA, Saccabusi S, et al. Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene. Int J Dermatol. 2001 Aug. 40(8):495-9. [Medline].

  25. Enzensberger R, Hunfeld KP, Elshorst-Schmidt T, et al. Disseminated cutaneous Mycobacterium marinum infection in a patient with non-Hodgkin's lymphoma. Infection. 2002 Dec. 30(6):393-5. [Medline].

  26. Farooqui MA, Berenson C, Lohr JW. Mycobacterium marinum infection in a renal transplant recipient. Transplantation. 1999 Jun 15. 67(11):1495-6. [Medline].

  27. Forsgren A. Antibiotic susceptibility of Mycobacterium marinum. Scand J Infect Dis. 1993. 25(6):779-82. [Medline].

  28. Galdiero M, Finamore E, Galdiero E, et al. A case of granulomatous skin lesions caused by Mycobacterium marinum in the Campania region. New Microbiol. 2005 Jan. 28(1):89-92. [Medline].

  29. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15. 175(4):367-416. [Medline].

  30. Harth M, Ralph ED, Faraawi R. Septic arthritis due to Mycobacterium marinum. J Rheumatol. 1994 May. 21(5):957-60. [Medline].

  31. Hartmark-Hill JR, Kanodia AK, Frey KA. 53-year-old man with a swollen finger. Mayo Clin Proc. 2008 Feb. 83(2):217-20. [Medline].

  32. Horowitz EA, Sanders WE. Other Mycobacterium Species. Mandell G, Bennett J, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995. 2264-73.

  33. Iijima S, Saito J, Otsuka F. Mycobacterium marinum skin infection successfully treated with levofloxacin. Arch Dermatol. 1997 Aug. 133(8):947-9. [Medline].

  34. Johnston JM, Izumi AK. Cutaneous Mycobacterium marinum infection ("swimming pool granuloma"). Clin Dermatol. 1987 Jul-Sep. 5(3):68-75. [Medline].

  35. Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med. 1993 Jun 1. 118(11):883-8. [Medline].

  36. Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis. 2003 Aug 1. 37(3):390-7. [Medline].

  37. Nguyen C. Images in clinical medicine. Mycobacterium marinum. N Engl J Med. 2004 Feb 26. 350(9):e8. [Medline].

  38. Petrini B. Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections. Eur J Clin Microbiol Infect Dis. 2006 Oct. 25(10):609-13. [Medline].

  39. Ramakrishnan L. Images in clinical medicine. Mycobacterium marinum infection of the hand. N Engl J Med. 1997 Aug 28. 337(9):612. [Medline].

  40. Rhomberg PR, Jones RN. In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum. Diagn Microbiol Infect Dis. 2002 Feb. 42(2):145-7. [Medline].

  41. Roddy K, Kao G, Dawn M, et al. The arthritic fisherman. Am J Med. 2008 Apr. 121(4):287-9. [Medline].

  42. Ryan JM, Bryant GD. Fish tank granuloma--a frequently misdiagnosed infection of the upper limb. J Accid Emerg Med. 1997 Nov. 14(6):398-400. [Medline].

  43. Saadatmand B, Poulton JK, Kauffman CL. Mycobacterium marinum with associated bursitis. J Cutan Med Surg. 1999 Apr. 3(4):218-20. [Medline].

  44. Shih JY, Hsueh PR, Chang YL, et al. Osteomyelitis and tenosynovitis due to Mycobacterium marinum in a fish dealer. J Formos Med Assoc. 1997 Nov. 96(11):913-6. [Medline].

  45. Sokol DK, Azzarelli B, Smith RR, et al. Primary intravascular lymphomatosis associated with Mycobacterium marinum. J Neuroimaging. 1998 Jan. 8(1):47-9. [Medline].

  46. Tan HH, Chan RK. Atypical mycobacterium infection with sporotrichoid spread in a patient with human immunodeficiency virus. Ann Acad Med Singapore. 1999 Nov. 28(6):846-8. [Medline].

  47. Vazquez JA, Sobel JD. A case of disseminated Mycobacterium marinum infection in an immunocompetent patient. Eur J Clin Microbiol Infect Dis. 1992 Oct. 11(10):908-11. [Medline].

  48. Weitzul S, Eichhorn PJ, Pandya AG. Nontuberculous mycobacterial infections of the skin. Dermatol Clin. 2000 Apr. 18(2):359-77, xi-xii. [Medline].

  49. Wendt JR, Lamm RC, Altman DI, et al. An unusually aggressive Mycobacterium marinum hand infection. J Hand Surg [Am]. 1986 Sep. 11(5):753-5. [Medline].

Previous
Next
 
Photograph of Mycobacterium marinum infection.
Photograph of Mycobacterium marinum infection.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.